stars 1 stars 2 stars 3

Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials. Aspect is advancing its therapeutic pipeline across multiple endocrine and metabolic diseases, including diabetes and rare endocrine disorders.

Aspect Biosystems Questions

The Aspect Biosystems annual revenue was $28.5 million in 2026.

Tamer Mohamed is the Founder and CEO of Aspect Biosystems.

110 people are employed at Aspect Biosystems.

Aspect Biosystems is based in Vancouver, British Columbia.

The NAICS codes for Aspect Biosystems are [54, 54171, 5417, 541713, 541, 541714].

The SIC codes for Aspect Biosystems are [873, 87].

Top Aspect Biosystems Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users